ABOS
Acumen Pharmaceuticals Inc
2.10$
+3.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2,866.9% | – | – | – | -15,289.3% | – | – | – | – | – | – | – | |
| – | 13.4% | – | – | – | 24.7% | – | – | – | – | – | – | – | |
| – | 563.4% | – | – | – | 1,316.3% | – | – | – | – | – | – | – | |
| – | 2,087.6% | – | – | – | 4,618.5% | – | – | – | – | – | – | – | |
| – | 4.8% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | -16,830.0% | – | – | – | 16,664.6% | – | – | – | – | – | – | – | |
| – | -0.1% | – | – | – | -5.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | 10,046.2% | – | – | – | -5.1% | – | – | – | – | – | – | – | |
| – | -9,650.7% | – | – | – | 1,372.5% | – | – | – | – | – | – | – | |
| – | -2,871.7% | – | – | – | -15,289.3% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.